Your browser doesn't support javascript.
loading
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18.
Kim, M; Lee, J L; Shin, S J; Bae, W K; Lee, H J; Byun, J H; Choi, Y J; Youk, J; Ock, C Y; Kim, S; Song, H; Park, K H; Keam, B.
Afiliación
  • Kim M; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; Cancer Research Institute, Seoul National University College of Medicine, Seoul.
  • Lee JL; Department of Oncology and Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
  • Shin SJ; Division of Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul.
  • Bae WK; Department of Hemato-Oncology, Chonnam National University Medical School & Hwasun Hospital, Hwasun.
  • Lee HJ; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon.
  • Byun JH; Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon.
  • Choi YJ; Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul.
  • Youk J; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; Cancer Research Institute, Seoul National University College of Medicine, Seoul.
  • Ock CY; Lunit, Seoul, Republic of Korea.
  • Kim S; Lunit, Seoul, Republic of Korea.
  • Song H; Lunit, Seoul, Republic of Korea.
  • Park KH; Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul.
  • Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul; Cancer Research Institute, Seoul National University College of Medicine, Seoul. Electronic address: bhumsuk@snu.ac.kr.
ESMO Open ; 8(4): 101588, 2023 08.
Article en En | MEDLINE | ID: mdl-37385153
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Biosimilares Farmacéuticos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: ESMO Open Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Biosimilares Farmacéuticos Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: ESMO Open Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido